AltruBio: Funding, Investors & Team (Oct 2026)
AltruBio is a biopharmaceutical company that is dedicated to creating targeted antibody treatments for cancer and immune-related inflammatory conditions. It is a global company based in Delaware with its main office in the San Francisco Bay Area, California. AbGenomics, with roots in Taipei, Taiwan since 2000, focuses on developing innovative therapies for medical conditions with unmet needs. Their research team has established a strong platform for discovering and validating new antibody treatments. AbGenomics currently has multiple potential therapeutic antibodies in development for autoimmune diseases, pancreatic cancer, stomach cancer, colorectal cancer, ovarian cancer, lung cancer, and other solid tumors.
AltruBio has raised $288M across 2 funding rounds on record, the most recent a Series B of $225M announced in May 2024.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
AltruBio Company Profile and Key Stats
Latest funding round on record: May 2024.
AltruBio Funding Rounds
AltruBio raised $63.0M in a Series A announced in Apr 2021.
3.1 years later, a Series B of $225M was announced in May 2024.
AltruBio Founders and Leadership Team
Contact details for the AltruBio team: 1 of 1 has an email address on file.
Start 14-day free trial →AltruBio Funding Compared to Other Biotechnology Startups
AltruBio's latest round of $225M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like AltruBio in Biotechnology and Los Altos
Companies Similar to AltruBio
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
AltruBio Funding FAQs
What does AltruBio do?
AltruBio is a biopharmaceutical company that is dedicated to creating targeted antibody treatments for cancer and immune-related inflammatory conditions. It is a global company based in Delaware with its main office in the San Francisco Bay Area, California. AbGenomics, with roots in Taipei, Taiwan since 2000, focuses on developing innovative therapies for medical conditions with unmet needs. Their research team has established a strong platform for discovering and validating new antibody treatments. AbGenomics currently has multiple potential therapeutic antibodies in development for autoimmune diseases, pancreatic cancer, stomach cancer, colorectal cancer, ovarian cancer, lung cancer, and other solid tumors.
How much funding has AltruBio raised?
AltruBio has raised $288M across 2 rounds on record. The most recent is a Series B of $225M announced in May 2024.
When did AltruBio last raise funding?
AltruBio's most recent funding round on record is a Series B of $225M, announced in May 2024.
Who founded AltruBio?
FundedIQ lists Judy Chou (Founder) at AltruBio.
Where is AltruBio headquartered?
AltruBio is based in Los Altos, California, United States.
How many employees does AltruBio have?
AltruBio is in the 11-50 employee band.
How does AltruBio's funding compare to other Biotechnology startups?
AltruBio's latest round of $225M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's AltruBio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AltruBio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.